| Name | | |
| Last NAV | 87.39 | 603.54 |
| Date of Valuation | 2025/11/26 | 2025/11/26 |
| Sharpe Ratio | -0.09 | N/A |
| 3-Year Risk Return Ratio | 1.56 | 0.53 |
| Cumulative Performance (%) |
| +13.38% | +6.90% |
| +29.26% | +13.61% |
| +65.07% | +15.43% |
| +125.70% | +11.69% |
| +6.46% | +9.37% |
| -10.59% | +23.27% |
| +34.55% | +20.08% |
| N/A | +867.99% |
| Calendar Year Performance (%) |
| +6.46% | +9.37% |
| -17.00% | -10.37% |
| -10.59% | +23.27% |
| +28.38% | +18.44% |
| +34.55% | +20.08% |
| 3-Year Annualised Volatility | 25.96% | 10.17% |
| Funds House | BlackRock Asset Management North Asia Limited | AllianceBernstein Hong Kong Ltd |
| Portfolio Manager | Evy Hambro & Tom Holl | John H. Fogarty, CFA & Vinay Thapar |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 4468870000 | USD 3744480000 |
| Base Currency | USD | USD |
| Sector | Gold & Precious Metals | Healthcare |
| Geographic Allocation | Global | Global |
| Top Holdings |
| AGNICO EAGLE MINES LTD (ONTARIO) (8.32%) | UnitedHealth Group, Inc. (8.40%) |
| BARRICK GOLD CORP (8.19%) | Roche Holding AG (5.81%) |
| NEWMONT CORPORATION (6.86%) | Novo Nordisk A/S (6.06%) |
| KINROSS GOLD CORP (6.17%) | Johnson & Johnson (3.62%) |
| NORTHERN STAR RESOURCES LTD (4.99%) | Vertex Pharmaceuticals (4.29%) |
| ALAMOS GOLD INC (PRE-REINCORPORATION) (4.76%) | Gilead Sciences (4.97%) |
| SPROTT PHYSICAL SILVER TRUST (4.13%) | Intuitive Surgical, Inc. (3.93%) |
| WHEATON PRECIOUS METALS CORP (4.06%) | Eli Lilly (8.48%) |
| LUNDIN GOLD INC (3.86%) | Regeneron Pharmaceuticals (3.57%) |
| ENDEAVOUR MINING PLC (5.43%) | Merck & Co., Inc. (5.79%) |
| Minimum Initial Investment | N/A | USD 2000 |
| Initial Sales Fee | Class A Shares: up to 5% of the price of shares.Class C Shares: Nil | Class A Shares: up to 5% of the purchase price. Not applicable to other Share Classes. |
| Switching Fee | Nil(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.), except a delayed Initial Charge of up to 5% of the price of Class A Shares may be payable upon switching newly acquired Shares in a Reserve Fund into this Fund. | Not Applicable |
| Maintenance Fee | Custodian Fees Safekeeping fees: 0.005% to 0.441%.Custodian Fees Transactional fees: US$8.8 to US$196 per transaction.Performance Fee : Nil.Administration Fee : Up to 0.25%(May be increased to a combined 2.25% maximum upon giving three months’ prior notice to shareholders.).Distribution Fee Class A Shares: Nil.Distribution Fee Class C Shares: 1.25%. | Contingent Deferred Sales Charge Class B Shares: Where applicable up to 4% (depending on years held) of the lesser of the current Net Asset Value or original cost of the Shares being redeemed. Contingent Deferred Sales Charge Class C Shares: Where applicable up to 1% (depending on years held) of the lesser of the current Net Asset Value or original cost of the Shares being redeemed. Contingent Deferred Sales Charge: Not applicable to other Share Classes. Distribution fee Class B Shares: 1.00% p.a. of average daily Net Asset Value. Distribution fee: Not applicable to other Share Classes. Administration Fee payable to the Management Company: 0.05% p.a. of average daily Net Asset Value. Custodian fee: These fees may decrease or increase depending on the assets of the Portfolio and transaction volume or for other reasons(Please refer to the prospectus for the latest annualized amounts expressed as a percentage of average daily Net Asset Value of the Portfolio for the respective fees.).Administration fee payable to the Administrator: Same as Custodian fee. Transfer Agent fee: Same as Custodian fee. The current annual rate may be increased up to specified permitted maximum level as set out in the offering document by giving up to 3 month(s) (as may be required by the SFC) prior notice to investors. |
| Redemption Fee | Nil.(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.) | Not Applicable |
| Launch Date | 1994/12/30 | 1995/07/05 |
| End of Financial Year | 31/08 | 31/05 |
| Country of Registry | Luxembourg | Luxembourg |
| Other Relevant Information | | |
| |